Replies to post #3804 on Calypte Biomedical Corp (fka CBMC)

[OttomanRosendahl]

and the Marr Group


Other participants included:

Dr. John Tedstrom, Executive Director of GBC;
Rajat Gupta, Chairman of the Global Fund to Fight AIDS, Tuberculosis and Malaria;
Professor Michel Kazatchkine, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria;
Peter Robertson, the Vice Chairman of Chevron;
Sidney Taurel, Chairman of Eli Lilly;
Clarence Cazalot Jr., President & CEO of Marathon Oil;
Sir Richard Branson, Founder and Chairman, Virgin Group;
Catherine Babington, President, Abbott Fund and Vice President for Public Affairs, Abbot Laboratories;
Ray Chambers, co-Chairman and founder of Malaria No More;
Vladimir Pozner, President of the Russian Television Academy Foundation;
Amy Robbins, Co-founder of the Mercury Fund;
Richard Plepler, Co-President of HBO;
Marat Safin, President of Marr Group;
Sir David Bell, Chairman of the Financial Times Group;
John Noel, CEO of the Noel Group;
Mikkel Vestergaard Frandsen, CEO of Vestergaard Frandsen;
Vladimir Golovnev, Founder and CEO of Vostok-Service.
About GBC
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) is an alliance of 220 international companies leading the business fight against HIV/AIDS, TB and malaria. GBC works to leverage the private sector’s unique skills and expertise in the global response – including developing comprehensive workplace policies; supporting community programs; utilizing core competencies; facilitating leadership and advocacy by business leaders; and brokering public-private partnerships. The official focal point of the private sector delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, GBC maintains offices in New York, Paris, Johannesburg, Beijing, Geneva, Nairobi, Moscow, and Kyiv.

[cato___]

Otto, are you attempting to answer the question I asked of Ceniise by replying to a post by Axiom?